An Outbreak of Community-Onset Methicillin-ResistantStaphylococcus aureusSkin Infections in Southwestern Alaska
- 1 June 2003
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 24 (6), 397-402
- https://doi.org/10.1086/502221
Abstract
Objective: We investigated a large outbreak of community-onset methicillin-resistantStaphylococcus aureus(MRSA) infections in southwestern Alaska to determine the extent of these infections and whether MRSA isolates were likely community acquired.Design: Retrospective cohort study.Setting: Rural southwestern Alaska.Patients: All patients with a history of culture-confirmed S.aureusinfection from March 1, 1999, through August 10, 2000.Results: More than 80% of culture-confirmed S.aureusinfections were methicillin resistant, and 84% of MRSA infections involved skin or soft tissue; invasive disease was rare. Most (77%) of the patients with MRSA skin infections had communityacquired MRSA (no hospitalization, surgery, dialysis, indwelling line or catheter, or admission to a long-term-care facility in the 12 months before infection). Patients with MRSA skin infections were more likely to have received a prescription for an antimicrobial agent in the 180 days before infection than were patients with methicillin-susceptible S.aureusskin infections.Conclusions: Our findings indicate that the epidemiology of MRSA in rural southwestern Alaska has changed and suggest that the emergence of community-onset MRSA in this region was not related to spread of a hospital organism. Treatment guidelines were developed recommending that beta-lactam antimicrobial agents not be used as a first-line therapy for suspectedS. aureusinfections.Keywords
This publication has 22 references indexed in Scilit:
- Epidemiology and Clonality of Community‐Acquired Methicillin‐ResistantStaphylococcus aureusin Minnesota, 1996–1998Clinical Infectious Diseases, 2001
- Methodological Principles of Case-Control Studies That Analyzed Risk Factors for Antibiotic Resistance: A Systematic ReviewClinical Infectious Diseases, 2001
- The Changing Epidemiology of Staphylococcus aureus?Emerging Infectious Diseases, 2001
- Involvement of Panton-Valentine Leukocidin--Producing Staphylococcus aureus in Primary Skin Infections and PneumoniaClinical Infectious Diseases, 1999
- Community‐Acquired Methicillin‐ResistantStaphylococcus aureusin Hospitalized Adults and Children without Known Risk FactorsClinical Infectious Diseases, 1999
- Methicillin-Resistant Staphylococcus aureus as a Community OrganismClinical Infectious Diseases, 1995
- Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxinsJournal of Medical Microbiology, 1995
- Efficacy of Trimethoprim-Sulfamethoxazole Against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus: A Report from TunisiaClinical Infectious Diseases, 1994
- Provision of Health Care in a Frontier Setting: An Alaskan PerspectiveJournal of the American Academy of Nurse Practitioners, 1992
- Staphylococcus aureus Leukocidin: A New Virulence Factor in Cutaneous Infections?Dermatology, 1992